发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 119 |
| England | 21 |
| Italy | 19 |
| Canada | 16 |
| Australia | 14 |
| CHINA MAINLAND | 12 |
| Belgium | 11 |
| GERMANY (FED REP GER) | 11 |
| Netherlands | 10 |
| France | 9 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| HARVARD UNIVERSITY | 36 |
| DANA-FARBER CANCER INSTITUTE | 25 |
| UNIVERSITY OF TEXAS SYSTEM | 22 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 19 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 17 |
| BRIGHAM & WOMEN'S HOSPITAL | 14 |
| MAYO CLINIC | 14 |
| YALE UNIVERSITY | 12 |
| UNIVERSITY OF LONDON | 11 |
| INSTITUT JULES BORDET | 10 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| MONARCH 3 final PFS: a randomized study of abemaciclib a... | 59 |
| Image analysis with deep learning to predict breast canc... | 24 |
| If we build it they will come: targeting the immune resp... | 17 |
| Exploration of PET and MRI radiomic features for decodin... | 16 |
| 21-Gene assay as predictor of chemotherapy benefit in HE... | 15 |
| Are all cyclin-dependent kinases 4/6 inhibitors created ... | 15 |
| Phase II study of ruxolitinib, a selective JAK1/2 inhibi... | 15 |
| Simultaneous defeat of MCF7 and MDA-MB-231 resistances b... | 13 |
| Cyclin E1 and Rb modulation as common events at time of ... | 12 |
| E2112: randomized phase iii trial of endocrine therapy p... | 12 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| CANCERS | 28 |
| INT J MOL SCI | 17 |
| BREAST CANCER RES | 15 |
| BREAST | 14 |
| BREAST CANCER RES TR | 14 |
| NPJ BREAST CANCER | 13 |
| SCI REP-UK | 13 |
| FRONT ONCOL | 11 |
| ANN SURG ONCOL | 10 |
| BMC CANCER | 10 |